Session Information
2013 Midyear Clinical Meeting
Click here to go to the previous page
Insulin Use in Hospitals: Recommendations for Decreasing Preventable Adverse Drug Events
Track:
Education Sessions (CE)
Program Code: 374-L05
Date: Monday, December 9, 2013
Time: 4:00 PM to 5:00 PM EST
Location:
W414 C, Level 4
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Daniel Cobaugh, PharmD, FAACT, Director of Research and Program Development, ASHP Research and Education Foundation Gregory Maynard
Robert Weber
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Daniel Cobaugh, PharmD, FAACT, Director of Research and Program Development, ASHP Research and Education Foundation- Describe types and incidence of insulin-related preventable adverse drug events in hospitals.
- Discuss challenges in implementing the insulin-use safety recommendations in hospitals.
- Discuss the current rate of adoption of the ASHP Foundation insulin-use recommendations.
- List recommendations from the ASHP Foundation for improving insulin-use safety in hospitals.
This session is a part of: